首站-论文投稿智能助手
典型文献
68Ga-PSMA ligand PET/CT integrating indocyanine green-guided salvage lymph node dissection for lymph node metastasis after radical prostatectomy
文献摘要:
To efficiently remove all recurrent lymph nodes(rLNs)and minimize complications,we developed a combination approach that consisted of 68Gallium prostate-specific membrane antigen(PSMA)ligand positron emission tomography(PET)/computed tomography(CT)and integrated indocyanine green(ICG)-guided salvage lymph node dissection(sLND)for rLNs after radical prostatectomy(RP).Nineteen patients were enrolled to receive such treatment.68Ga-PSMA ligand PET/CT was used to identify rLNs,and 5 mg of ICG was injected into the space between the rectum and bladder before surgery.Fluorescent laparoscopy was used to perform sLND.While extensive LN dissection was performed at level I,another 5 mg of ICG was injected via the intravenous route to intensify the fluorescent signal,and laparoscopy was introduced to intensively target stained LNs along levels Ⅰ and Ⅱ,specifically around suspicious LNs,with 68Ga-PSMA ligand PET/CT.Next,both lateral peritonea were exposed longitudinally to facilitate the removal of fluorescently stained LNs at levels Ⅲ and Ⅳ.In total,pathological analysis confirmed that 42 nodes were rLNs.Among 145 positive LNs stained with ICG,24 suspicious LNs identified with 68Ga-PSMA ligand PET/CT were included.The sensitivity and specificity of 68Ga-PSMA ligand PET/CT for detecting rLNs were 42.9%and 96.6%,respectively.For ICG,the sensitivity was 92.8%and the specificity was 39.1%.At a median follow-up of 15(interquartile range[IQR]:6-31)months,15 patients experienced complete biochemical remission(BR,prostate-specific antigen[PSA]<0.2 ng ml-1),and 4 patients had a decline in the PSA level,but it remained>0.2 ng ml-1.Therefore,"Ga-PSMA ligand PET/CT integrating ICG-guided sLND provides efficient sLND with few complications for patients with rLNs after RP.
文献关键词:
作者姓名:
Teng-Cheng Li;Yu Wang;Chu-Tian Xiao;Ming-Zhao Li;Xiao-Peng Liu;Wen-Tao Huang;Liao-Yuan Li;Ke Li;Jin-Ming Di;Xing-Qiao Wen;Xin Gao
作者机构:
Department of Urology,The Third Affiliated Hospital,Sun Yat-sen University,Guangzhou 510630,China
引用格式:
[1]Teng-Cheng Li;Yu Wang;Chu-Tian Xiao;Ming-Zhao Li;Xiao-Peng Liu;Wen-Tao Huang;Liao-Yuan Li;Ke Li;Jin-Ming Di;Xing-Qiao Wen;Xin Gao-.68Ga-PSMA ligand PET/CT integrating indocyanine green-guided salvage lymph node dissection for lymph node metastasis after radical prostatectomy)[J].亚洲男性学杂志(英文版),2022(01):97-101
A类:
rLNs,68Gallium,sLND,peritonea
B类:
PSMA,ligand,PET,integrating,indocyanine,green,guided,salvage,lymph,dissection,metastasis,after,radical,prostatectomy,To,efficiently,remove,recurrent,nodes,minimize,complications,developed,combination,approach,that,consisted,membrane,antigen,positron,tomography,computed,integrated,ICG,RP,Nineteen,patients,were,enrolled,receive,such,treatment,was,used,identify,injected,into,space,between,rectum,bladder,before,surgery,Fluorescent,laparoscopy,While,extensive,performed,another,via,intravenous,route,intensify,signal,introduced,intensively,target,stained,along,levels,specifically,around,suspicious,Next,both,lateral,exposed,longitudinally,facilitate,removal,fluorescently,In,total,pathological,analysis,confirmed,Among,positive,identified,included,sensitivity,specificity,detecting,respectively,For,At,median,follow,up,interquartile,range,IQR,months,experienced,complete,biochemical,remission,BR,PSA,ml,had,decline,but,remained,Therefore,provides,few
AB值:
0.438559
相似文献
Glycolytic potential enhanced by blockade of pyruvate influx into mitochondria sensitizes prostate cancer to detection and radiotherapy
Huan Xu;Junyi Chen;Zhi Cao;Xi Chen;Caihong Huang;Jin Ji;Yalong Xu;Junfeng Jiang;Yue Wang;Guowang Xu;Lina Zhou;Jingyi He;Xuedong Wei;Jason Boyang Wu;Zhong Wang;Shancheng Ren;Fubo Wang-Department of Urology,Shanghai Changhai Hospital,Second Military Medical University,Shanghai 200433,China;Department of Urology,Shanghai Ninth People's Hospital,Shanghai 200011,China;Department of Urology,the Second Affiliated Hospital of Fujian Medical University,Quanzhou 362000,China;Department of Urology,No.971 Hospital of the People's Liberation Army Navy,Qingdao 266000,China;Center for Genomic and Personalized Medicine,Guangxi Key Laboratory for Genomic and Personalized Medicine,Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine,Guangxi Medical University,Nanning 530021,China;Research Center of Developmental Biology,Second Military Medical University,Shanghai 200433,China;Dalian Institute of Chemical Physics,Chinese Academy of Sciences,Dalian 116023,China;Department of Urology,the First Affiliated Hospital of Soochow University,Suzhou 215006,China;Department of Pharmaceutical Sciences,College of Pharmacy and Pharmaceutical Sciences,Washington State University,Spokane,WA 99202,USA
The ratio of superior mesenteric artery diameter to superior mesenteric vein diameter based on non-enhanced computed tomography in the early diagnosis of spontaneous isolated superior mesenteric artery dissection
Yuan-li Lei;Wen-xing Song;Yi Lin;Hui-ping Li;He-ping Lyu;Jiao-zhen Chen;Zhang-ping Li;Jia-na Yin;Ji-ke Xue;Shou-quan Chen-Department of Emergency Medicine,the First Affiliated Hospital of Wenzhou Medical University,Wenzhou 325000,China;Department of Radiology,the First Affiliated Hospital of Wenzhou Medical University,Wenzhou 325000,China;Department of Gastroenterology,the First Affiliated Hospital of Wenzhou Medical University,Wenzhou 325000,China;Department of Vascular Surgery,the First Affiliated Hospital of Wenzhou Medical University,Wenzhou 325000,China;Department of Electrocardiogram,Wenzhou People's Hospital,Wenzhou 325000,China
Value of contrast-enhanced ultrasound combined with percutaneous ultrasound-guided fine-needle aspiration in the diagnosis of solid pancreatic lesions
Gui Yang;Dai Menghua;Meng Zhilan;Chang Xiaoyan;Tan Li;Zhang Jing;Chen Xueqi;Zhou Tongtong;Zhang Qing;Xiao Mengsu;Lyu Ke;Jiang Yuxin-Department of Ultrasound, State Key Laboratory of Complex Severe and Rare Diseases, Pecking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng District, Beijing 100730, China;Department of Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Pecking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng District, Beijing 100730, China;Department of Pathology, State Key Laboratory of Complex Severe and Rare Diseases, Pecking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng District, Beijing 100730, China
Prognostic and incremental value of computed tomography-based radiomics from tumor and nodal regions in esophageal squamous cell carcinoma
Bangrong Cao;Kun Mi;Wei Dai;Tong Liu;Tianpeng Xie;Qiang Li;Jinyi Lang;Yongtao Han;Lin Peng;Qifeng Wang-Radiation Oncology Key Laboratory of Sichuan Province Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610041,China;Department of Biobank Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610041,China;Department of Thoracic Surgery Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610041,China;Department of Medical Imaging Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610041,China;Department of Radiation Oncology,Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610041,China
Predictors of pathologic complete response in patients with residual flat mucosal lesions after neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Changlong Li;Zhen Guan;Yi Zhao;Tingting Sun;Zhongwu Li;Weihu Wang;Zhexuan Li;Lin Wang;Aiwen Wu-Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Gastrointestinal Cancer Center,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Radiology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Pathology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Radiation Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Cancer Epidemiology,Peking University Cancer Hospital&Institute,Beijing 100142,China
Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer: A pragmatic, multicenter, and prospective clinical trial in China
Binghe Xu;Huiping Li;Zefei Jiang;Lin Gu;Jinhai Tang;Hui Xie;Yueyin Pan;Yunjiang Liu;Shude Cui;Xiaojia Wang;Li Cai;Yiqiong Zhang;Huadong Zhao;Zhimin Shao-Department of Medical Oncology,National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Breast Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Department of Breast Cancer,the Fifth Medical Center of Chinese PLA General Hospital,Beijing 100071,China;Department of Breast Cancer,Tianjin Cancer Institute and Hospital,Tianjin 300060,China;Department of Breast Cancer,Jiangsu Provincial Hospital,Nanjing 210029,China;Department of Breast Cancer,the First Affiliated Hospital of China University of Science and Technology,Hefei 230001,China;Department of Breast Cancer,the Fourth Hospital of Hebei Medical University,Shijiazhuang 050011,China;Department of Breast Cancer,Henan Cancer Hospital,Zhengzhou 450008,China;Department of Breast Cancer,Zhejiang Cancer Hospital,Hangzhou 310012,China;Department of Breast Cancer,Harbin Medical University Cancer Hospital,Harbin 150081,China;Department of Clinical Development,Pfizer(China)R&D Co.Ltd,Shanghai 201203,China;Department of Statistics,Pfizer(China)R&D Co.Ltd,Shanghai 201203,China;Department of Breast Surgery,Shanghai Cancer Center/Cancer Institute,Shanghai Medical College,Fudan University,Shanghai 200032,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。